Literature DB >> 4275629

The effects of acute administration of propranolol and practolol on the uptake, content, release, and turnover of noradrenaline in the rat heart in vivo.

B Lemmer, R Saller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4275629     DOI： 10.1007/bf00647405

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  36 in total

1.  [THE EFFECT OF DRUGS ON THE ELIMINATION OF NORADRENALIN FROM PERFUSION FLUID AND NORADRENALIN UPTAKE IN THE ISOLATED HEART].

Authors:  R LINDMAR; E MUSCHOLL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-28

2.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

3.  Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.

Authors:  I M Mazurkiewicz-Kwilecki; A Romagnoli
Journal:  J Pharm Pharmacol       Date:  1970-03       Impact factor: 3.765

4.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

5.  Accumulation of norepinephrine in rat tissue following treatment with three beta-adrenergic antagonists.

Authors:  T C Westfall
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-05

Review 6.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

7.  The inhibition of noradrenaline uptake by drugs.

Authors:  L L Iversen
Journal:  Adv Drug Res       Date:  1965

8.  The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart.

Authors:  J W Foo; A Jowett; A Stafford
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

9.  Differences in the uptake, storage and metabolism of (+)- and (-)-noradrenaline.

Authors:  L L Iversen; B Jarrott; M A Simmonds
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

10.  Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities.

Authors:  G Wiethold; D Hellenbrecht; B Lemmer; D Palm
Journal:  Biochem Pharmacol       Date:  1973-06-15       Impact factor: 5.858
View more
  5 in total

1.  Physical activity decreases the number of beta-adrenergic receptors on human lymphocytes.

Authors:  W Krawietz; E M Klein; C Unterberg; M Ackenheil
Journal:  Klin Wochenschr       Date:  1985-01-15

2.  Concentration of catecholamines in human cardiac muscle.

Authors:  M C Petch; W G Nayler
Journal:  Br Heart J       Date:  1979-03

3.  Antagonism by chlorisondamine and propranolol, but not by atenolol, of the circadian phase-dependent phentolamine-induced changes in the cardiac noradrenaline turnover in the rat.

Authors:  B Lemmer; A Charrier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

4.  Correlation of platelet taurine levels with thyroid function.

Authors:  S I Baskin; S J Klekotka; Z V Kendrick; D G Bartuska
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

5.  Influence of beta-adrenoceptor blocking agents on the turnover rate of cardiac and splenic noradrenaline in rats.

Authors:  J M Alexandre; C Chevillard
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.